Nexgel (NXGLW) Asset Utilization Ratio (2019 - 2025)
Nexgel (NXGLW) reported Asset Utilization Ratio of 1.03 for Q4 2025, up 28.33% on a YoY basis from 0.81 in Q4 2024, and down 5.43% quarter-over-quarter from 1.09 in Q3 2025.
Nexgel (NXGLW) Asset Utilization Ratio (2019 - 2025) Analysis & Trends
Nexgel has reported Asset Utilization Ratio for 7 years, with the latest figure at 1.03 in Q4 2025.
- For the quarter ending Q4 2025, Asset Utilization Ratio rose 28.33% year-over-year to 1.03; the trailing twelve-month figure through Dec 2025 stood at 1.03 (up 28.33% YoY), and the FY2025 full-year result was 1.07, up 28.36% from the prior year.
- Asset Utilization Ratio for Q4 2025 stood at 1.03, down from 1.09 in the prior quarter.
- The five-year high for Asset Utilization Ratio was 1.16 in Q2 2025, with the low at 0.11 in Q1 2022.
- Historically, Asset Utilization Ratio has averaged 0.47 across 5 years, with a median of 0.31 in 2021.
- Annual changes were most pronounced in 2022 — Asset Utilization Ratio plunged 56.13% — and 2025, when it soared 133.15%.
- Nexgel's Asset Utilization Ratio stood at 0.14 in 2021, then jumped by 34.06% to 0.19 in 2022, then soared by 116.55% to 0.41 in 2023, then surged by 96.11% to 0.81 in 2024, then increased by 28.33% to 1.03 in 2025.
- The last three Asset Utilization Ratio figures came in at 1.03 (Q4 2025), 1.09 (Q3 2025), and 1.16 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 0.52 |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 0.40 |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 0.64 |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 0.77 |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 0.58 |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 0.34 |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 0.65 |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 0.54 |
| 10 | Nexgel | - | - | 819,000.00 | 1.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.03 |
| Sep 30, 2025 | 1.09 |
| Jun 30, 2025 | 1.16 |
| Mar 31, 2025 | 0.95 |
| Dec 31, 2024 | 0.81 |
| Sep 30, 2024 | 0.66 |
| Jun 30, 2024 | 0.50 |
| Mar 31, 2024 | 0.47 |
| Dec 31, 2023 | 0.41 |
| Sep 30, 2023 | 0.35 |
| Jun 30, 2023 | 0.27 |
| Mar 31, 2023 | 0.21 |
| Dec 31, 2022 | 0.19 |
| Sep 30, 2022 | 0.16 |
| Jun 30, 2022 | 0.13 |
| Mar 31, 2022 | 0.11 |
| Dec 31, 2021 | 0.14 |
| Sep 30, 2021 | 0.25 |
| Jun 30, 2021 | 0.27 |
| Mar 31, 2021 | 0.25 |